このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Aerobic Exercises Versus Sub Occipital Myofascial Release on Memory Function in Females With Premenstrual Syndrome.

2026年6月29日 更新者:Gehad Mohamed Ali Ahmed、Cairo University
This study will be conducted to investigate the effect of aerobic exercises versus sub occipital Myofascial release on memory functions in females with premenstrual syndrome.

調査の概要

状態

まだ募集していません

詳細な説明

The pooled prevalence of reproductive age women affected with premenstrual syndrome (PMS) worldwide amounts to 47.8%. Among these, about 20% of women experience symptoms severe enough to disrupt their daily activities, and the remaining have mild to moderate symptoms. They can experience an exacerbation of insomnia, memory problems, difficulty maintaining focus, and fatigue in the both follicular phase and luteal phase, but more noticed during the luteal phase. Memory deficit could affect those women social activities and one's daily positive functioning. Therefore, some females and their providers seek alternative treatments such as Aerobic exercise which represents a cost-effective, widely available, natural, and self-administered treatment with no adverse side effects, and it is reported that Aerobic exercise resulted in 16.5% increase in hippocampal volume and 53.7% increase in memory, as well as increased hippocampal resting-state functional connectivity.

And also, it is found the noticed role of suboccipital muscles release in improving memory functions through enhancing cerebral blood flow to the brain via vertebral artery, and also regulation of cortisol level that interferes with memory and stress.

Till now, there is no previous study illustrating the difference between the effect of aerobic exercise and sub occipital muscle release on memory functions in females with PMS. So, this study will be the first one in this issue. Therefore, it will have valuable benefits in physical therapy field and scientific research.

研究の種類

介入

入学 (推定)

40

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

Females with premenstrual syndrome and memory function deficits have to meet the following criteria in order to participate in this study:

  • Their age ranged from 18 to 30 years old.
  • Their body mass index (BMI) ranged from 18.5 - 30 kg/cm2.

Exclusion Criteria:

  • Any medications that can affect central nervous system or memory function.
  • Any neurological disorders affect their memory function.
  • Pregnant women.
  • Daily smokers.
  • Had a concussion or head trauma within the past 30 days.
  • Took any illegal drugs or alcohol within the past 30 days.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Aerobic exercise group
The participants will receive aerobic exercise program for 30 minutes, 3 sessions per week for 6 weeks.
A moderate-intensity aerobic exercise session on a treadmill consists of three phases: warm-up, active phase, and cool-down. The warm-up lasts 5-10 minutes and involves walking at minimum speed (2.0 - 3.0 km/h) with a slight incline (1 -2%) or as tolerated. The active phase, lasting 20-30 minutes, maintains a brisk walking or light jogging pace with moderate speed (4.5-6.5 km/h) or as tolerated. This phase can include steady-state jogging or intervals of walking and jogging to sustain cardiovascular engagement. Finally, the cool-down phase lasts 5-10 minutes, where the speed is gradually reduced to 2.0 - 3.0 km/h, allowing the heart rate to decrease safely.
実験的:Sub occipital myofascial release group
The participants will receive sub occipital myofascial release treatment 3 sessions per week for 6weeks.
The patient will be asked to take a supine position, and a pillow will be placed under the patient's head for comfort until starting the procedure, the patient will be instructed to be relaxed, then the therapist will sit at the head of the bed and will place both hands underneath the patient's head in the occipital region. The therapist should then feel for the occipital ridge along the scalp and move the hands slightly caudal until the muscle is felt. The therapist then will flex the fingers upward against the suboccipital muscles and this position will be hold for 3 to 5 minutes or until significant muscle tension will be released.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Memory function
時間枠:6 weeks

Assessment of memory function will be done by the free recall test. The word list will contain 10 words selected randomly. These words would be administered to the patient one by one with interval time 1 second between each word with total words presentation time 10 seconds.

The presentation of these words will be though a digital screen using a designed video showing these words arranged in order with a fixed interval 1 second between each word.

The patient will be instructed immediately to recall these words verbally at any order.

The total score is 10 and one point will be accounted for each word will be recalled correctly

6 weeks
Prospective and retrospective memory questionnaire (PRMQ)
時間枠:6 weeks

It will be used to assess memory functions. The measure consists of 16 individual items.

The Structure of the PRMQ consists of 16 Items total , each item is rated on a 5-point scale (1 = Never , 2 = Rarely , 3 = Sometimes , 4 = Often , 5 = Very Often). These 16 items, evenly divided into 8 prospective memory items and 8 retrospective memory items. Each item describes a common memory lapse, giving a high score to an item means a high memory deficits at that item. The total score ranges from 16 to 80, with higher scores indicating a greater frequency of memory lapse and deficit.

6 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Perceived Stress Scale (PSS)
時間枠:6 weeks
The Perceived Stress Scale (PSS) is a widely used self-report instrument developed to to assess the degree to which individuals perceive situations in their lives as stressful during the previous month. The most commonly used version, the 10-item Perceived Stress Scale (PSS-10), consists of 10 questions rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often). Participants complete the questionnaire independently, the total score is obtained by summing the responses to all items, resulting in a score ranging from 0 to 40, with higher scores indicating greater perceived stress. Although there are no universally accepted cut-off values, scores of 0-13 are generally considered to indicate low perceived stress, 14-26 moderate perceived stress, and 27-40 high perceived stress.
6 weeks
Cervical pain intensity
時間枠:6 weeks
The Visual Analogue Scale (VAS) will be used to assess pain intensity. It is a simple, valid, and reliable self-report instrument widely used to assess the intensity of subjective symptoms such as pain, stress, fatigue, and mood. It consists of a 10-cm horizontal line with two endpoints representing the extremes of the symptom being measured (e.g., "no pain" at one end and "worst imaginable pain" at the other). Participants are instructed to place a mark on the line at the point that best represents the intensity of their current symptom. The score is determined by measuring the distance in millimeters or centimeters from the left endpoint to the participant's mark, yielding a value ranging from 0 to 100 mm (or 0-10 cm), with higher scores indicating greater symptom intensity.
6 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディチェア:Amel Youssef, professor、Cairo University
  • スタディディレクター:Elham Hassan, As Professor、Cairo University

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年7月3日

一次修了 (推定)

2026年9月20日

研究の完了 (推定)

2026年9月30日

試験登録日

最初に提出

2026年6月29日

QC基準を満たした最初の提出物

2026年6月29日

最初の投稿 (実際)

2026年7月6日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月6日

QC基準を満たした最後の更新が送信されました

2026年6月29日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する